 |
|
Complications Associated With Implantable Cardioverter-Defibrillator Replacement in Response to Device Advisories
Paul A. Gould, MBBS, PhD;
Andrew D. Krahn, MD; for the Canadian Heart Rhythm Society Working Group on Device Advisories
JAMA. 2006;295:1907-1911.
Context Recent implantable cardioverter-defibrillator (ICD) advisories and recalls have caused management dilemmas for physicians, particularly because there are no specific guidelines or data on outcomes from current management strategies. The risk of ICD generator replacement has not been assessed in this population.
Objective To determine the complication rate associated with ICD generator replacement for the current ICD advisories.
Design and Setting Seventeen ICD implanting centers in Canada were surveyed to assess complication rates as a result of generator replacements because of ICD advisories from October 2004 to October 2005.
Main Outcome Measure Complications associated with elective ICD generator replacement for current device advisories.
Results At the 17 surveyed centers, 2915 patients had recall devices, including 533 (18.3%) who had advisory ICDs replaced a mean (SD) of 26.5 (11.5) months after their initial implant. Of these patients, 66% had a secondary prevention ICD, and 45% had received a previous appropriate shock. During a mean (SD) of 2.7 (2.8) months' follow-up after ICD generator replacement, complications occurred in 43 patients (8.1%). Major complications attributable to advisory device replacement requiring reoperation occurred in 31 patients (5.8%), with death in 2 patients after extraction for pocket infection. Minor complications occurred in 12 patients (2.3%). There were 3 (0.1%) advisory-related device malfunctions reported, without clinical consequences.
Conclusions ICD generator replacement in patients with advisory devices is associated with a substantial rate of complications, including death. These complications need to be considered in the development of guidelines determining the appropriate treatment of patients with advisory devices.
Author Affiliations: Division of Cardiology, Department of Medicine, University of Western Ontario, London.
RELATED ARTICLES
Pacemaker and ICD Generator Malfunctions: Analysis of Food and Drug Administration Annual Reports
William H. Maisel, Megan Moynahan, Bram D. Zuckerman, Thomas P. Gross, Oscar H. Tovar, Donna-Bea Tillman, and Daniel B. Schultz
JAMA. 2006;295(16):1901-1906.
ABSTRACT
| FULL TEXT
Pacemaker and ICD Generator Reliability: Meta-analysis of Device Registries
William H. Maisel
JAMA. 2006;295(16):1929-1934.
ABSTRACT
| FULL TEXT
Pacemaker and ICD Malfunction—An Incomplete Picture
Bruce L. Wilkoff
JAMA. 2006;295(16):1944-1946.
EXTRACT
| FULL TEXT
Implantable Cardioverter-Defibrillators
Janet M. Torpy, Alison E. Burke, and Richard M. Glass
JAMA. 2006;295(16):1964.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
A Critical Appraisal of Implantable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death
Tung et al.
J Am Coll Cardiol 2008;52:1111-1121.
ABSTRACT
| FULL TEXT
Longevity of implantable cardioverter-defibrillators: implications for clinical practice and health care systems
Biffi et al.
Europace 2008;0:eun240v1-8.
ABSTRACT
| FULL TEXT
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons
Epstein et al.
J Am Coll Cardiol 2008;51:e1-e62.
FULL TEXT
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons
Epstein et al.
Circulation 2008;117:e350-e408.
FULL TEXT
Troubleshooting implantable cardioverter-defibrillator related problems
van Erven and Schalij
Heart 2008;94:649-660.
FULL TEXT
A 59-Year-Old Man Considering Implantation of a Cardiac Defibrillator
Zimetbaum
JAMA 2007;297:1909-1916.
ABSTRACT
| FULL TEXT
Permanent Pacemaker and Implantable Cardioverter Defibrillator Infection: A Population-Based Study
Uslan et al.
Arch Intern Med 2007;167:669-675.
ABSTRACT
| FULL TEXT
Update in Critical Care 2006
Milbrandt et al.
Am. J. Respir. Crit. Care Med. 2007;175:638-648.
FULL TEXT
The cost of implantable defibrillators: how the perception of reality depends on perspective
Heidbuchel
Eur Heart J 2007;0:ehl518v1-2.
FULL TEXT
Contemporary Pacemaker and Defibrillator Device Therapy: Challenges Confronting the General Cardiologist
Schoenfeld
Circulation 2007;115:638-653.
FULL TEXT
The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator
Yao et al.
Eur Heart J 2007;28:42-51.
ABSTRACT
| FULL TEXT
Management of recalled pacemakers and implantable cardioverter-defibrillators: a decision analysis model.
Amin et al.
JAMA 2006;296:412-420.
ABSTRACT
| FULL TEXT
ICD Replacement Is Not Benign
Journal Watch Cardiology 2006;2006:3-3.
FULL TEXT
Pacemaker and ICD malfunction--an incomplete picture.
Wilkoff
JAMA 2006;295:1944-1946.
FULL TEXT
|
